Detail of the clinical trial

Title of the trial A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia with 17p Deletion
EudraCT number 2013-003314-41
Protocol number GS-US-312-0133
Sponsor Gilead Sciences, Inc.,333 Lakeside Drive,Foster City, CA,94404
Indications Hematology
Diagnosis chronic lymphocytic leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 12.8.2014
Date of approval by EC 5.11.2014
Date of initiation CT in ČR 22.4.2015
Date of ending CT in ČR 22.3.2016
Notice
Sites Fakultni nemocnice Olomouc,Hemato-onkologicka klinika,I.P. Pavlova 6,Olomouc,775 20
Vseobecna fakultni nemocnice v Praze,1. interni klinika - klinika hematologie,U nemocnice 1,Praha 2,128 08
Fakultni nemocnice Hradec Kralove,IV. interni hematologicka klinika,Sokolska 581,Hradec Kralove,500 05
Fakultni nemocnice Kralovske Vinohrady,Interni hematologicka klinika,Srobarova 50,Praha 10,100 34
Fakultni nemocnice Brno,Interni hematoonkologicka klinika,Jihlavska 20,Brno,625 00
Fakultni nemocnice Ostrava,Klinika hematoonkologie,17. listopadu 1790,Ostrava,708 52

‹‹ Back to list